Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy UBS Group AG

Start price
€47.50
07.01.26 / 50%
Target price
€55.55
07.01.27
Performance (%)
1.37%
Price
€48.15
15:31
Summary
This prediction is currently active. With a performance of 1.37%, the BUY prediction by UBS_Group_AG for Bristol-Myers Squibb is trending in the right direction. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w
Bristol-Myers Squibb 1.37%
iShares Core DAX® 2.659%
iShares Nasdaq 100 0.916%
iShares Nikkei 225® 2.426%
iShares S&P 500 1.230%

Comments by UBS_Group_AG for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) 1.37%
Target price 55.549
Change
Ends at 07.01.27

Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock.
Ratings data for BMY provided by MarketBeat